FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
RELATED ARTICLES
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
New Horizon Health finds formula for profits ahead of schedule
6606.HK
-
Burning Rock narrows losses with drug research as new driver
BNR.US
- FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
-
Sales success comes with side effects for drug maker BeiGene
BGNE.US 6160.HK
- CHINA BULLETIN: Six New BRICS
Discover hidden China stock gems in our weekly newsletter